查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012040

術中磁振造影市場：2026-2032年全球市場預測（依磁場強度、掃描器類型、系統類型、應用程式和最終用戶分類）

Intraoperative MRI Market by Field Strength, Scanner Type, System Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，術中 MRI 市場價值將達到 20.9 億美元，到 2026 年將成長至 23.2 億美元，到 2032 年將達到 48 億美元，複合年成長率為 12.62%。

主要市場統計數據
基準年 2025 20.9億美元
預計年份：2026年 23.2億美元
預測年份 2032 48億美元
複合年成長率 (%) 12.62%

對術中 MRI 的發展歷程、臨床促進因素和整合挑戰進行了權威概述，闡述了其在現代外科手術計畫中的應用。

術中磁振造影（MRI）已從一種輔助手段轉變為不可或缺的工具，重新定義了手術的精準度和手術全期決策。本文概述了臨床、技術和組織方面的促進因素如何共同推動MRI在各個醫學專科領域的應用。磁鐵設計、影像序列以及與手術流程整合的進步，使醫療團隊能夠在確認切緣的同時保留病患功能，最大限度地減少再次手術，並降低併發症率。同時，低場硬體的改進、便攜性解決方案以及與手術器械的兼容性，正在拓展可應用即時成像技術的手術範圍。

技術整合、工作流程整合和臨床證據的形成如何從根本上改變術中 MRI 的引入和實踐？

術中磁振造影領域正經歷一場變革，其驅動力來自於技術創新、不斷湧現的臨床證據以及醫療服務模式的轉變。磁鐵工程和影像處理軟體的最新進展降低了術中應用的門檻，使得高解析度、高場強解決方案以及可靈活適應各種手術環境的低場強系統成為可能。同時，移動式和固定式系統設計的出現，使得醫療機構能夠根據手術量和設施限制調整資本投入。除了這些硬體創新之外，影像序列和術中通訊協定的改進，例如增強組織對比度、減少偽影和縮短擷取時間，也使得術中磁振造影更能適應手術節奏。

2025 年美國關稅措施對術中 MRI 專案採購、供應鏈韌性和業務連續性的連鎖反應。

隨著全球供應鏈和貿易政策的演變，美國將於2025年實施的關稅政策已成為術中成像解決方案製造商、經銷商和醫療系統面臨的關鍵因素。這些關稅措施對關鍵組件的採購決策產生了重大影響，這些組件包括超導性材料、特殊梯度材料以及某些通常在多個司法管轄區生產的電子子系統。為此，供應商被迫重新評估籌資策略，選擇替代供應商，並在某些情況下重新設計組件以降低受影響關稅項目的風險。因此，供應鏈的重新檢驗和雙重供應商的採用縮短了生產前置作業時間。

細分市場層面的洞察揭示了磁場強度、掃描器架構、系統便攜性、臨床應用和最終用戶環境如何決定技術選擇和臨床工作流程。

對系統細分的深入理解有助於明確臨床需求與技術能力和採購偏好之間的相互作用。根據磁場強度，系統可分為高場型和低場型。高場型系統具有高固有對比度和空間解析度，有利於複​​雜的神經外科切除術切除；而低場型系統面積更小，屏蔽要求更低，並且與現有手術室基礎設施的兼容性更好。根據掃描儀類型，封閉式和開放式系統之間的差異會影響患者的操作和術中工作效率。封閉式系統通常在頭部和某些身體部位的手術中提供穩定的影像質量，而開放式系統則便於手術操作和成像過程中的病患監護。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和基礎設施現狀正在塑造術中 MRI 引入的路徑和支援模式。

區域趨勢對監管路徑、採購行為和臨床應用模式有顯著影響。在美洲，成熟的神經外科中心和綜合醫療保健系統，在緊密的轉診網路和集中的研究活動的支持下，推動了複雜腦腫瘤切除術和先進術中通訊協定的早期應用。該地區對模組化服務合約和資金籌措模式的需求也十分旺盛，這些模式能夠使資本投資與營運能力和臨床結果的預期相匹配。

競爭和服務主導因素正在重塑術中 MRI 生態系統中的供應商策略、整合模式和臨床夥伴關係。

競爭格局由少數幾家成熟的製造商、新興的專業供應商以及專注於整合、培訓和生命週期支援的服務供應商組成。成熟的技術供應商繼續利用其深厚的工程技術專長和臨床夥伴關係關係，提供全面的服務包，以擴展模組化、改善影像排序並降低部署和運行過程中的機構風險。同時，新興的專業參與企業則透過提高靈活性、減少屏蔽要求和簡化使用者介面等設計選擇來脫穎而出，從而降低手術室團隊將術中成像技術整合到日常工作流程中的門檻。

為醫療保健領導者提供實用的操作和策略建議，以最佳化術中 MRI 技術的選擇、實施、培訓和結果評估。

產業領導者和醫院經營團隊可以採取實際行動，確保術中磁振造影技術的成功實施，並最大限度地發揮其臨床效益。首先，應讓相關人員參與計劃規劃的早期階段，明確病例組成、工作流程目標和培訓需求，以確保技術選擇基於手術實際需求，而非受供應商遊說。其次，應優先考慮包含生命週期支援、備件供應和明確服務等級協定 (SLA)的籌資策略，以保障手術安排並確保可預測的正常運作。第三，應考慮混合實施模式，將用於分散式存取的行動系統與用於複雜病例的集中式固定設備相結合，從而最佳化資金配置和臨床覆蓋範圍。

我們採用透明、以證據為基礎的研究途徑，整合臨床文獻、技術文件和相關人員訪談，為決策者提供可操作的見解。

本執行摘要的研究採用綜合方法，結合了對同行評審的臨床研究、技術白皮書、監管申報文件和供應商產品文件的系統性回顧，並輔以對臨床負責人、採購專家和系統整合商的定性訪談。來自多個獨立資訊來源的資訊經過交叉檢驗，建構了關於技術趨勢、應用促進因素和營運挑戰的連貫敘述。研究強調長期臨床證據和實際部署經驗，以確保洞察是基於實際應用，而非單純的市場標語。

整體結論強調了術中 MRI 計畫的臨床價值、實施要求和成功所需的操作前提條件。

總之，術中磁振造影在以單階段根治性手術和最佳組織保留效果為優先目標的外科手術方案中正發揮著日益重要的作用。磁場強度柔軟性、掃描器架構和系統便攜性方面的技術創新，拓展了術中成像的臨床應用範圍，並使其更具實用價值。同時，關鍵專科領域證據的積累，也明確了術中磁振造影能夠帶來可衡量的臨床獲益的領域，促使更多醫學界領導者將此項技術視為提升外科手術水平的戰略投資之一。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 以磁場強度分類的術中磁振造影市場

  • 高磁場
  • 低磁場

第9章：按掃描器類型分類的術中磁振造影市場

  • 封閉式
  • 開孔

第10章：按系統類型分類的術中磁振造影市場

  • 移動系統
  • 靜止系統

第11章 術中磁振造影市場：依應用領域分類

  • 心血管系統
  • 神經外科
    • 開顱手術
    • 脊椎手術
  • 腫瘤學
    • 切片檢查指南
    • 腫瘤切除
  • 整形外科

第12章 術中磁振造影市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第13章 術中磁振造影市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 術中磁振造影市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 術中磁振造影市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國術中磁振造影市場

第17章 中國術中磁振造影市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Allengers Medical Systems Ltd
  • Aspect Imaging Ltd
  • Aurora Imaging Technology
  • Brainlab AG
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Carl Zeiss AG
  • Esaote SpA
  • FONAR Corporation
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc
  • Hitachi Ltd
  • Hyperfine Inc
  • IMRIS
  • Koninklijke Philips NV
  • Medtronic plc
  • NeuroLogica Corp
  • Neusoft Medical Systems Co Ltd
  • Shenzhen Anke High-Tech Co Ltd
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Stryker Corporation
  • Synaptive Medical
  • Time Medical Systems
  • United Imaging Healthcare Co Ltd
Product Code: MRR-43539E5D2DD1

The Intraoperative MRI Market was valued at USD 2.09 billion in 2025 and is projected to grow to USD 2.32 billion in 2026, with a CAGR of 12.62%, reaching USD 4.80 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.09 billion
Estimated Year [2026] USD 2.32 billion
Forecast Year [2032] USD 4.80 billion
CAGR (%) 12.62%

An authoritative overview of intraoperative MRI evolution, clinical drivers, and integration challenges shaping adoption across modern surgical programs

Intraoperative magnetic resonance imaging has transitioned from a novel adjunct to an integral tool that reshapes surgical precision and perioperative decision-making. This introduction frames the clinical, technological, and organizational drivers that have converged to accelerate adoption across specialty practices. Advances in magnet design, imaging sequences, and integration with surgical workflows are enabling teams to verify resection margins, minimize repeat procedures, and reduce complication rates while preserving function. At the same time, improvements in low-field hardware, mobility solutions, and compatibility with operative instrumentation are widening the spectrum of procedures that can incorporate real-time imaging.

Clinicians, hospital administrators, and device planners are navigating a more complex landscape where clinical efficacy must align with operational constraints and staff competencies. Reimbursement pathways and evidence generation through prospective studies are shaping institutional willingness to invest, while technology vendors are responding with modular systems and service models that emphasize workflow integration and training. Consequently, the narrative of intraoperative MRI is one of pragmatic innovation: technologies are maturing into practical solutions that address demonstrated clinical needs, yet successful deployment requires multidisciplinary alignment, robust change management, and clear measures of patient-centered value.

How technological convergence, workflow integration, and clinical evidence formation are driving a fundamental reshaping of intraoperative MRI adoption and practice

The intraoperative MRI landscape is undergoing transformative shifts driven by converging technological innovation, evolving clinical evidence, and changes in care delivery models. Recent advances in magnet engineering and imaging software have reduced the barriers to intraoperative use, enabling both high-fidelity high-field solutions and flexible low-field systems that can be accommodated in a variety of operating environments. Simultaneously, the emergence of movable and stationary system designs has created options for institutions to align capital investment with procedural volumes and facility constraints. These hardware innovations are complemented by improved imaging sequences and intraoperative protocols that enhance tissue contrast, mitigate artifacts, and shorten acquisition times, thereby making intraoperative MRI more compatible with the tempo of surgery.

Beyond hardware, workflow-centric developments-such as integration with neuronavigation platforms, instrument-tracking technologies, and intraoperative planning tools-are shifting the value proposition from image acquisition alone to comprehensive intraoperative decision support. In parallel, the clinical evidence base for intraoperative MRI, particularly in neurosurgical tumor resection and select orthopedic and oncologic applications, is solidifying. This evidence is catalyzing new care pathways that prioritize single-stage definitive procedures over staged interventions. Finally, the vendor landscape is responding with service models emphasizing training, remote support, and outcome monitoring, which further lowers implementation risk and accelerates clinician confidence in intraoperative MRI.

The ripple effects of United States tariff measures in 2025 on procurement, supply chain resilience, and operational continuity for intraoperative MRI programs

As global supply chains and trade policies evolve, tariff dynamics introduced in the United States in 2025 have become a salient factor for manufacturers, distributors, and health systems involved with intraoperative imaging solutions. These tariff measures have materially affected the sourcing calculus for core components including superconducting materials, specialized gradients, and certain electronic subsystems that are often manufactured across multiple jurisdictions. In response, suppliers have had to reassess procurement strategies, qualify alternative vendors, and in some instances redesign components to mitigate exposure to affected tariff lines. This has resulted in near-term increases in production lead times as supply chains were revalidated and dual-sourcing options were operationalized.

Clinicians and hospital procurement teams have observed the downstream effects as capital procurement cycles adjusted to account for extended lead times and revised delivery schedules. Consequently, institutions have prioritized strategic procurement planning and closer collaboration with vendors to establish guaranteed delivery windows and transparent component sourcing. At the same time, manufacturers have accelerated regionalization and in-country assembly where feasible to minimize tariff sensitivity and provide more resilient delivery commitments. These operational shifts have implications for service contracts and spare-part logistics, prompting health systems to revisit lifecycle support agreements to ensure continuity of care and minimize the risk of equipment downtime during critical surgical periods.

Segment-level insights that reveal how field strength, scanner architecture, system mobility, clinical application, and end-user setting determine technology selection and clinical workflows

A nuanced understanding of system segmentation clarifies where clinical needs intersect with technological capabilities and procurement preferences. Based on Field Strength, systems fall into high-field and low-field categories, with high-field designs delivering higher intrinsic contrast and spatial resolution that benefit complex neurosurgical resections, while low-field platforms offer reduced footprint, simpler shielding requirements, and enhanced compatibility with existing operating room infrastructures. Based on Scanner Type, the distinction between closed bore and open bore systems influences patient access and intraoperative ergonomics, where closed bore units typically provide robust image quality for head and select body procedures and open bore designs facilitate surgical access and patient monitoring during imaging.

Further segmentation by System Type differentiates movable systems from stationary systems, an important operational axis that affects capital allocation, room conversion needs, and scheduling flexibility. Movable systems present a compelling choice for facilities seeking to distribute imaging capability across multiple suites without permanent room conversion, whereas stationary systems are often selected by high-volume centers prioritizing image fidelity and integrated OR design. Based on Application, intraoperative MRI is utilized across cardiovascular, neurosurgery, oncology, and orthopedic procedures, with neurosurgery further categorized into craniotomy and spinal surgery subtypes that reflect divergent imaging and workflow requirements; oncology applications are further distinguished between biopsy guidance and tumor resection, each demanding tailored imaging sequences and intraoperative decision protocols. Finally, based on End User, adoption pathways differ between ambulatory surgical centers and hospitals, with hospitals typically investing in integrated programs that support complex, multidisciplinary cases and ambulatory centers favoring cost-effective, streamlined systems suited to high-throughput elective procedures.

Regional dynamics and infrastructure realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape adoption pathways and support models for intraoperative MRI

Regional dynamics influence regulatory pathways, procurement behavior, and clinical adoption patterns in meaningful ways. In the Americas, established centers of neurosurgical excellence and integrated health systems have driven early adoption for complex brain tumor resections and advanced intraoperative protocols, supported by dense referral networks and concentrated research activity. This region also exhibits significant demand for modular service arrangements and financing models that align capital investment with operational throughput and clinical outcomes expectations.

In Europe, the Middle East & Africa, institutional diversity leads to heterogeneous adoption patterns: advanced tertiary centers pursue high-field stationary installations to support cutting-edge neurosurgical programs, while resource-constrained facilities assess lower-field or movable options to balance clinical benefits against infrastructure and staffing considerations. Regulatory harmonization and cross-border clinical collaborations further shape procurement decision cycles and evidence generation efforts. In the Asia-Pacific region, rapid expansion of surgical capacity, progressive hospital modernization, and targeted investments in specialty care drive interest in both movable and fixed solutions, with an emphasis on scalability, service reliability, and local support networks. Across these regions, localized training programs, reimbursement frameworks, and supply chain considerations are pivotal in determining the pace and shape of intraoperative MRI adoption.

Competitive and service-driven forces that are reshaping vendor strategies, integration models, and clinical partnerships in the intraoperative MRI ecosystem

The competitive landscape is defined by a small number of established manufacturers, emerging specialized vendors, and service providers focusing on integration, training, and lifecycle support. Established technology providers continue to leverage deep engineering expertise and clinical partnerships to extend modularity, improve imaging sequences, and offer comprehensive service packages that reduce institutional risk during deployment and operation. At the same time, specialist entrants are differentiating through design choices that emphasize mobility, reduced shielding requirements, and simplified user interfaces that lower the barrier for OR teams to adopt intraoperative imaging into routine workflows.

Service partners and systems integrators play an increasingly important role by offering project management, training, and outcome-monitoring programs that translate product capabilities into reliable clinical performance. Collaboration between vendors and clinical centers has produced standardized protocols and shared datasets that inform procedural best practices, while warranty and remote-support models are evolving to ensure uptime and rapid issue resolution. Importantly, procurement preferences reflect a balance between clinical ambition and operational pragmatism: high-volume centers prioritize image fidelity and throughput, whereas smaller facilities emphasize flexibility, total cost of ownership, and vendor responsiveness. These trends underscore the necessity for vendors to pair strong technical offerings with robust commercial and clinical support capabilities.

Actionable operational and strategic recommendations for healthcare leaders to optimize technology selection, deployment, training, and outcome measurement for intraoperative MRI

Industry leaders and hospital executives can take concrete actions to accelerate successful implementation and maximize clinical benefit from intraoperative MRI. First, align clinical stakeholders early in project planning to define case mix, workflow objectives, and training requirements so that technology selection is driven by procedural needs rather than vendor persuasion. Second, prioritize procurement strategies that incorporate lifecycle support, spare-part availability, and clearly defined service-level agreements to protect operative schedules and ensure predictable uptime. Third, consider hybrid deployment models that pair movable systems for distributed access with a centralized stationary unit for complex cases, thereby optimizing capital allocation and clinical coverage.

Fourth, invest in structured training programs and simulation-based credentialing to shorten the clinician learning curve and embed imaging protocols into routine practice. Fifth, establish outcome-monitoring frameworks that track key clinical indicators such as reoperation rates, procedure times, and patient-centered functional outcomes, and use those data to refine protocols and justify continued investment. Finally, maintain close collaboration with vendors to co-develop incremental improvements in imaging protocols, OR ergonomics, and integration with navigation and surgical planning tools, ensuring that technology evolution remains tightly coupled to clinical priorities and operational constraints.

A transparent, evidence-focused research approach integrating clinical literature, technical documentation, and stakeholder interviews to produce actionable insights for decision-makers

The research synthesis underpinning this executive summary combines a structured review of peer-reviewed clinical studies, technical white papers, regulatory filings, and vendor product documentation, complemented by qualitative interviews with clinical leads, procurement specialists, and systems integrators. Information was triangulated across multiple independent sources to develop a coherent narrative of technological trends, adoption drivers, and operational challenges. Emphasis was placed on longitudinal clinical evidence and real-world deployment experiences to ensure that insights are grounded in practical implementation realities rather than promotional statements.

Analytical rigor was applied to interpret device design attributes, workflow implications, and supply-chain vulnerabilities, with attention to variant use-cases across neurosurgery, oncology, orthopedics, and cardiovascular applications. Careful consideration was given to regional regulatory contexts and procurement practices, and sensitivity was maintained to the interplay between clinical efficacy and operational feasibility. Where direct comparative data were limited, qualitative expert judgment was used to synthesize likely programmatic outcomes, and all conclusions prioritize reproducibility and transparency in the underlying assumptions and data sources.

Synthesized conclusions highlighting the clinical value, implementation imperatives, and operational prerequisites for successful intraoperative MRI programs

In conclusion, intraoperative MRI occupies an increasingly central role in surgical programs that prioritize single-stage definitive interventions and superior tissue-sparing outcomes. Technological innovations in field strength versatility, scanner architecture, and system mobility have expanded the set of clinical settings where intraoperative imaging is practical and beneficial. At the same time, evidence maturation in key specialties has clarified where intraoperative MRI delivers measurable clinical benefits, prompting more healthcare leaders to evaluate this modality as part of strategic investments in surgical excellence.

Implementation success depends on more than device performance: it requires integrated planning across clinical teams, procurement, and service partners, as well as ongoing training and outcome measurement. Supply-chain and trade policy developments necessitate proactive procurement planning and robust vendor partnerships to ensure continuity of service. Ultimately, institutions that thoughtfully align clinical objectives with technology selection, training investments, and outcome monitoring will be best positioned to convert intraoperative MRI capability into demonstrable patient and system value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intraoperative MRI Market, by Field Strength

  • 8.1. High Field
  • 8.2. Low Field

9. Intraoperative MRI Market, by Scanner Type

  • 9.1. Closed Bore
  • 9.2. Open Bore

10. Intraoperative MRI Market, by System Type

  • 10.1. Movable Systems
  • 10.2. Stationary Systems

11. Intraoperative MRI Market, by Application

  • 11.1. Cardiovascular
  • 11.2. Neurosurgery
    • 11.2.1. Craniotomy
    • 11.2.2. Spinal Surgery
  • 11.3. Oncology
    • 11.3.1. Biopsy Guidance
    • 11.3.2. Tumor Resection
  • 11.4. Orthopedic

12. Intraoperative MRI Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. Intraoperative MRI Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Intraoperative MRI Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Intraoperative MRI Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Intraoperative MRI Market

17. China Intraoperative MRI Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Allengers Medical Systems Ltd
  • 18.6. Aspect Imaging Ltd
  • 18.7. Aurora Imaging Technology
  • 18.8. Brainlab AG
  • 18.9. Bruker Corporation
  • 18.10. Canon Medical Systems Corporation
  • 18.11. Carl Zeiss AG
  • 18.12. Esaote S.p.A.
  • 18.13. FONAR Corporation
  • 18.14. FUJIFILM Holdings Corporation
  • 18.15. GE HealthCare Technologies Inc
  • 18.16. Hitachi Ltd
  • 18.17. Hyperfine Inc
  • 18.18. IMRIS
  • 18.19. Koninklijke Philips N.V.
  • 18.20. Medtronic plc
  • 18.21. NeuroLogica Corp
  • 18.22. Neusoft Medical Systems Co Ltd
  • 18.23. Shenzhen Anke High-Tech Co Ltd
  • 18.24. Shimadzu Corporation
  • 18.25. Siemens Healthineers AG
  • 18.26. Stryker Corporation
  • 18.27. Synaptive Medical
  • 18.28. Time Medical Systems
  • 18.29. United Imaging Healthcare Co Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAOPERATIVE MRI MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRAOPERATIVE MRI MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA INTRAOPERATIVE MRI MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GCC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 133. GCC INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. GCC INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. GCC INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. GCC INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. G7 INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. G7 INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 157. G7 INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. G7 INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. G7 INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. NATO INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. NATO INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 165. NATO INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. NATO INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. NATO INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 169. NATO INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA INTRAOPERATIVE MRI MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)